hACE2 Protein (ECD)

€590.00

Price excl. shipping costs excl. VAT. For more information, see our shipping policy

SKU: P2020-016_100 trenzyme

Contact us for a quote

Need a quote for an individual request or for a bulk order?

Please contact us.

Description

P2020-016: The human Angiotensin-Converting Enzyme 2 (hACE2) is a protein highly expressed at the surface of cells of the human lungs, arteries, kidney, heart and intestine and is shown to be the entry receptor for SARS-CoV-2 infection. The hACE2 protein is one of the most important components for Coronavirus research to develop effective therapies for COVID-19. Our recombinant human ACE2 protein (ECD, processed) and tag-free has high quality and is excellent for SARS-CoV2 R&D.

--

P2020-024: The human Angiotensin-Converting Enzyme 2 (hACE2) is a protein highly expressed at the surface of cells of the human lungs, arteries, kidney, heart and intestine and is shown to be the entry receptor for SARS-CoV-2 infection. The hACE2 protein is one of the most important components for Coronavirus research to develop effective therapies for COVID-19.

----

P2020-017: The human angiotensin-converting enzyme 2 (hACE2) has been shown to be the entry receptor for SARS-CoV-2 infection. Therefore, hACE2 protein is one of the most important components for Coronavirus research to develop effective therapies for COVID-19. Our high-quality biotinylated hACE2 protein (ECD) with Avi/His tag is ideal for SARS-CoV-2 research and development.

---

P2020-037: The hACE2 protein is among the most important components for coronavirus research to develop effective therapies for COVID-19, as it has been shown to be an entry receptor for SARS-CoV-2 infection hACE2 is highly expressed on tissue surfaces that have been shown to harbor SARS-CoV - these include the surface of cells of the human lung, arteries, kidneys, heart and intestine. Our non-biotinylated hACE Protein is made in Germany and shows high purity and quality.

trenzyme cellebrity kolben

Get in contact with us


By submitting this form, I consent to trenzyme GmbH receiving and processing my data in order to process my inquiry. My consent is voluntary and I may revoke this consent at any time without providing any reasons, e.g. by sending an email to privacy(at)trenzyme.com with effect for the future. Further notices on data processing can be found in our privacy policy.